{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised crossover study included 10 adult patients undergoing cerebral bypass surgery."
      },
      "Participants": {
        "score": 1,
        "evidence": "10 adult patients undergoing cerebral bypass surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients randomly and sequentially received dobutamine to increase cardiac index or phenylephrine to increase mean arterial pressure (MAP)."
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesised that cardiac output, rather than arterial blood pressure, is essential for adequate perfusion and aimed to determine whether dobutamine administration resulted in greater graft perfusion than phenylephrine administration."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the absolute difference in graft flow between the reference and intervention phase."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients randomly and sequentially received dobutamine to increase cardiac index or phenylephrine to increase mean arterial pressure (MAP)."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This randomised crossover study included 10 adult patients undergoing cerebral bypass surgery."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Graft flow increased with a median of 4.1 (inter-quartile range [IQR], 1.7\u201312.0] ml min \u22121 ) after dobutamine administration and 3.6 [IQR, 1.3\u20137.8] ml min \u22121 after phenylephrine administration (difference \u20130.6 ml min \u22121 ; 95% confidence interval [CI], \u201314.5 to 5.3; P =0.441)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Clinical trial registration: Netherlands Trial Register, NL7077 ( https://www.trialregister.nl/trial/7077 )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}